Actively Recruiting
Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy
Led by Fondation Ophtalmologique Adolphe de Rothschild · Updated on 2026-01-05
250
Participants Needed
3
Research Sites
279 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The patient presents to the ophthalmological emergencies and / or to the internal medicine department. NOIA clinical discovery Patient referred in radiology for brain and visual MRI. The two sequences added by the research (8 minutes) will be added to that of the treatment.
CONDITIONS
Official Title
Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient over 18 years old
- Suspected anterior ischemic optic neuropathy (NOIA) confirmed by a specialized ophthalmologist
- Planned brain and visual MRI
- Provided written consent to participate
- Covered by a Social Security scheme
You will not qualify if you...
- Contraindication to MRI (such as electrical device, metallic foreign body, or claustrophobia)
- Under legal protection measures
- Pregnant or breastfeeding woman
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
CHU de LILLE
Lille, Lille, France, 59000
Not Yet Recruiting
2
Fondation A De Rothschild
Paris, PARIS, France, 75019
Actively Recruiting
3
Chu Rouen
Rouen, France, 76100
Not Yet Recruiting
Research Team
A
Amelie YAVCHITZ
CONTACT
S
sidney krystal
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here